Global Aesthetic Implants Medical Devices Pipeline Market Report 2021 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Aesthetic Implants - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

"Aesthetic Implants - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Aesthetic Implants pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Aesthetic Implants are the devices intended to enhance the physical appearance and improve their image. Implantation is usually performed for cosmetic purposes as well as to rectify the deformed shape of the organ.

Scope

• Extensive coverage of the Aesthetic Implants under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Aesthetic Implants and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Aesthetic Implants under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

2 Introduction

2.1 Aesthetic Implants Overview

3 Products under Development

3.1 Aesthetic Implants - Pipeline Products by Stage of Development

3.2 Aesthetic Implants - Pipeline Products by Segment

3.3 Aesthetic Implants - Pipeline Products by Territory

3.4 Aesthetic Implants - Pipeline Products by Regulatory Path

3.5 Aesthetic Implants - Pipeline Products by Estimated Approval Date

3.6 Aesthetic Implants - Ongoing Clinical Trials

4 Aesthetic Implants - Pipeline Products under Development by Companies

4.1 Aesthetic Implants Companies - Pipeline Products by Stage of Development

4.2 Aesthetic Implants - Pipeline Products by Stage of Development

5 Aesthetic Implants Companies and Product Overview

5.1 Allergan Aesthetics Company Overview

5.2 Apex Medical Device Design LLC Company Overview

5.3 Arula Technologies Company Overview

5.4 BellaSeno GmbH Company Overview

5.5 Collplant Biotechnologies Ltd Company Overview

5.6 Establishment Labs SA Company Overview

5.7 HansBiomed Co Ltd Company Overview

5.8 Innovia LLC Company Overview

5.9 Lattice Medical Company Overview

5.10 Mentor Worldwide LLC Company Overview

5.11 Neosthetic, LLC Company Overview

5.12 Oxtex Ltd Company Overview

5.13 Plcoskin Company Overview

5.14 Prayasta 3D Inventions Pvt Ltd Company Overview

5.15 Sientra Inc Company Overview

5.16 Tensive SRL Company Overview

5.17 TeVido BioDevices LLC Company Overview

5.18 Uronext LLC Company Overview

6 Aesthetic Implants- Recent Developments

6.1 Oct 27, 2021: FDA strengthens safety requirements and updates study results for breast implants

6.2 Oct 19, 2021: Sientra and Mission Plasticos launch reshaping lives: Full Circle a philanthropic initiative for women living in poverty in America

6.3 Oct 11, 2021: CollPlant's rhCollagen BioInk used by Technion researchers to develop 3D Bioprinted vascularized tissue constructs

6.4 Sep 22, 2021: 'Aesthetic One' app developed by The Aesthetic Society registers over 6, 000 breast implants

6.5 Apr 07, 2021: PatientFi Adds Veteran Banking Executive Gerry Cuddy to its Board of Directors

6.6 Mar 31, 2021: Acellular dermal matrix (ADM) products used in implant-based breast reconstruction differ in complication rates: FDA safety communication

7 Appendix

Companies Mentioned

• Allergan Aesthetics
• Apex Medical Device Design LLC
• Arula Technologies
• BellaSeno GmbH
• Collplant Biotechnologies Ltd
• Establishment Labs SA
• HansBiomed Co Ltd
• Innovia LLC
• Lattice Medical
• Mentor Worldwide LLC
• Neosthetic, LLC
• Oxtex Ltd
• Plcoskin
• Prayasta 3D Inventions Pvt Ltd
• Sientra Inc
• Tensive SRL
• TeVido BioDevices LLC
• ronext LLC

For more information about this report visit https://www.researchandmarkets.com/r/q0r715